Analyst’s Review to Watch: Chemours Company (NYSE:CC)

Chemours Company (NYSE:CC) shares traded 3.31% up during most recent session to reach at the closing price of $45.27. The stock exchanged hands 5.14 Million shares versus average trading capacity of 2.59 Million shares, yielding a market cap of $8.35 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $44 within the next 52-weeks. The mean target projections are based on 7 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Chemours Company (NYSE:CC) high price target of $50 and with a conservative view have low price target of $35.

JP Morgan “Upgrades” Chemours Company (NYSE:CC) in a research note issued to investors on 5/12/17 to Overweight with price target of $0.

Additionally on 3/29/17 Jefferies “Upgrades” Chemours Company (NYSE:CC) to Buy setting price target at $48 and on 2/17/17 Susquehanna “Upgrades” the stock to Positive at $0. Furthermore on 12/12/16 Goldman Sachs “Downgrades” the stock to Neutral at $0.

On the other hand the company has Relative Strength Index (RSI 14) of 74.97 along with Average True Range (ATR 14) of 1.59, Consequently Chemours Company (NYSE:CC)’s weekly and monthly volatility is 4.03%, 3.70% respectively. The company’s beta value is at 0.

In terms of Buy, Sell or Hold recommendations, Chemours Company (NYSE:CC) has analysts’ mean recommendation of 2.3. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Chemours Company (NYSE:CC)’s minimum EPS for the current quarter is at $0.75 and can go high up to $0.89. The consensus mean EPS for the current quarter is at $0.82 derived from a total of 6 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.27 earnings per share for the same quarter during last year.

Previously Chemours Company (NYSE:CC) reported $0.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.5 by $0.25. The company posted an earnings surprise of 50%.

Chemours Company (NYSE:CC)’s revenue estimates for the current quarter are $1.48 Billion according to 3 number of analysts, for the current quarter the company has high revenue estimates of $1.49 Billion in contradiction of low revenue estimates of $1.48 Billion. For the current year the company’s revenue estimates are $5.72 Billion compared to low analyst estimates of $5.38 Billion and high estimates of $5.97 Billion according to 6 number of analysts.

Currently Chemours Company (NYSE:CC)’s shares owned by insiders are 0.5%, whereas shares owned by institutional owners are 78.9%. However the six-month change in the insider ownership was recorded -2.25%, as well as three-month change in the institutional ownership was recorded 1.29%.

Chemours Company (NYSE:CC) 52-week high price stands at $44.40 and low price stands at $5.79, its price distance from 52-week high is 1.96% while its distance from 52-week low price is 681.66%. The stock hit its 52-week high on 05/15/17, and 52-week low on 07/06/16.

Chemours Company (NYSE:CC)’s trailing twelve month revenues are $5.54 Billion, whereas its price to sales ratio for the same period is 1.44. Its book value per share for the most recent quarter is $1.92 while its price to book ratio for the same period is 23.58, as for as the company’s cash per share for the most recent quarter is $5.09, however its price to cash per share ratio for the same period is 8.89. The stock has 5 year expected PEG ratio of 55.58 whereas its trailing twelve month P/E ratio is 83.37.

Previous ArticleNext Article